The 5' untranslated region (UTR) of c-myc (which is well conserved amongst species) plays a signi®cant role in modulating the steady state levels of the c-myc protein. A translational control mechanism residing in the ®rst exon was originally postulated by Saito et al. arising from dierential hypothetical secondary structures as a result of chromosomal translocations (Saito et al., 1983) . In addition, c-myc mRNAs lacking exon 1 were found to be translated more eciently in vitro when compared to full length transcripts (Darveau et al., 1985) . Furthermore, a 240 nt restrictive element within exon 1 of murine c-myc was isolated and shown to inhibit translation of heterologous mRNAs in rabbit reticulocyte lysate and wheat germ extract (Parkin et al., 1988) demonstrating that the 5' UTR is highly structured and inhibitory to the scanning mechanism of translation. However, early studies in vivo examining translational eciencies of c-myc mRNA in Burkitt's lymphoma cell lines suggested that both truncated and full length transcripts were translated with equal eciencies (Nilsen and Maroney, 1984) . Moreover, when expressed in numerous cell lines or translated in HeLa cell extracts the 5' UTR does not inhibit translation of either c-myc or reporter genes (Butnick et al., 1985; Parkin et al., 1988) . This disparity suggests that non-canonical factors, which are lacking in rabbit reticulolysate and wheat germ extract, facilitate c-myc translation through the 5' UTR in vivo (Parkin et al., 1988) .
Translational regulation mediated through the 5' UTR is not unique to c-myc. Many cellular mRNAs encoding proto-oncogenes, growth factors, receptors and transcription factors possess long, highly structured 5' UTRs which aect their regulation (Gray and Hentze, 1994) . For the overwhelming majority of eukaryotic mRNAs, where initiation of protein synthesis occurs via a cap-dependent mechanism (involving binding of the eukaryotic initiation factor (eIF) 4E, to the 7 methyl G cap of the mRNA, for review see Hershey, 1991) , such elements in¯uence translation of the mRNA by repressing this capdependent mechanism. Alternatively, structured 5' UTRs may contain an internal ribosome entry segment (IRES) which allows cap-independent translation. These IRESes are capable of directing ribosomes to an internal start codon which may be some considerable distance (600 ± 1000 nts) from the 5' end of the message (for reviews see Jackson et al., 1994 . The eukaryotic mRNAs which have so far been demonstrated to contain IRESes include the human immunoglobulin heavy chain binding protein (Macejak and Sarnow, 1991) , basic ®broblast growth factor (Vagner et al., 1995) and eukaryotic initiation factor 4G (Gan and Rhoads, 1996) . These may exemplify a group of mRNAs whose translation is required even when capdependent activity is compromised. However, to date no mechanisms have been elucidated for these eukaryotic IRESes and the cellular circumstances under which internal ribosome entry is required have yet to be fully de®ned (Sarnow, 1989; Vagner et al., 1995) .
In cell lines derived from patients with Bloom's syndrome and Multiple Myeloma we have shown that de-regulated c-myc expression occurred by a translational mechanism (West et al., 1995; Paulin et al., 1996) and in the latter case a speci®c mutation was found in the 5' UTR of c-myc. In this paper we demonstrate that the 5' UTR of c-myc contains an IRES. This is the ®rst example of a proto-oncogene which can utilise such a method to initiate protein synthesis and deregulation of c-myc via such a mechanism would have profound implications for tumorigenesis.
c-myc 5' UTR does not inhibit translation in cultured cells
Four promoters have been identi®ed in the c-myc proto-oncogene; P1, P2, P3 and P0 which give rise to transcripts of approximately 2.4 kb, 2.25 kb, 2.0 kb and 3.1 kb respectively (Battey et al., 1983; Bentley and Groudine, 1986; Yang et al., 1985) . P2 is the major promoter from which 75 ± 90% of cellular transcripts originate, with P1 producing only 10 ± 25% (Stewart et al., 1984) . Transcripts initiated at P0, P1 and P2 give rise to 5' untranslated regions of approximately 1000, 600 and 400 nucleotides respectively. In vitro studies on the 5' UTR of the P2 transcript have demonstrated that this region is highly structured and inhibitory to ribosome scanning (Darveau et al., 1985; Parkin et al., 1988) . To determine the eect of 5' UTR in vivo, we inserted a 396 bp segment into the plasmid pGL3 (Promega) directly upstream of the coding region for ®re¯y luciferase to create the plasmid construct pGL3utr ( Figure 1a ). The pGL3utr construct and the control vector pGL3 were transfected into HeLa and HepG2 cells. The 5' UTR was not found to inhibit the downstream luciferase expression (Figure 1b) hence the activity of luciferase produced from pGL3utr was 1.2 ± 1.6-fold higher than that produced from the control vector pGL3 (Figure 1b ). a b Figure 1 (a) Construction of monocistronic vectors. The c-myc 5' UTR was ampli®ed using the primers FP2501. 5'-TAATTCCAGCGAGAGGCAGA-3' and MS4519 5'-ATACCATGGTCGCGGGAGGCTGCT-3'. Ampli®cation resulted in a fragment of 396 bp which is contained within the region from 2501 ± 4519 in the genomic sequence (Watt et al., 1983) . This sequence was inserted into the control vector pGL3 (Promega) proximal to the ®re¯y luciferase (FL) gene, using the PvuII and NcoI sites creating the vector pGL3utr. (b) The eect of the c-myc 5' UTR on a downstream cistron. HeLa and HepG2 cells were transfected with 20 mg of the luciferase constructs (pGL3 or pGL3utr) and 5 mg of the b-galactosidase construct pcDNA3.1/HisB/Lacz (Invitrogen) by the calcium phosphate method (Ausubel et al., 1987) . Cells were harvested after 48 h and luciferase expression was determined using a luciferase assay system (Promega) and b-galactosidase expression was determined using a Galactolight plus system (Tropix). Both activities were measured in a 1253 Luminometer (BioOrbit). Variations in transfection eciency were corrected by normalising luciferase activity to b-galactosidase activity. The results presented are an average of three independent experiments To create the vector pGL3R which contains two luciferase genes, the coding region of the Renilla luciferase (RL) gene was obtained from the vector pRL-CMV (Promega) by digestion with NheI and XbaI. To extend the length of the 3' UTR, this fragment was blunt end ligated into the HindIII site of pSKBluescript (Stratagene) and subsequently excised using EcoRV and XhoI. This DNA segment was blunt-end ligated into the EcoRV site of pGL3. Finally, a chimeric intron from pRL-CMV was blunt-end ligated into the HindIII site to minimise utilisation of cryptic splice sites. The 5' UTR of c-myc (generated as in Figure 1a ) was inserted into pGL3R at PvuII and NcoI sites to create the vector pGL3Rutr. (b) Expression of Renilla and ®re¯y luciferase from dicistronic mRNAs in HeLa and HepG2 cells. The dicistronic constructs were transfected into HeLa and HepG2 cells as before. Both luciferase activities were measured using the Dual-Luciferase reporter assay system (Promega). The values were normalised to b-galactosidase activity as in Figure 1 and luciferase activities obtained are expressed relative to those obtained for pGL3R. The results presented are an average from three independent experiments. (c) An oligonucleotide cassette 5'-AGATCTGGTACCGAGCTCCCCGGGCTGCAGGAT-3' and 5'-ATCCTGCAGCCCGGGGACC-TCGGTACCAGATCT-3' containing an internal PstI site was inserted into the EcoRV site of pGL3Rutr. This vector was digested with PstI and EcoRV and the same oligonucleotide cassette was excised with PstI and ligated into these sites creating a 60 bp palindronic sequence upstream of the Renilla coding sequence. This results in the production of a hairpin structure with an energy of 755 Kcal/mol. The vector was transfected into HeLa cells and luciferase activity measured as before. The luciferase activities were normalised to b-galactosidase and expressed relative to those obtained from vector pGL3Rutr. The results presented are an average of three independent experiments c-myc 5' UTR contains an IRES M Stoneley et al c-myc 5' UTR contains an internal ribosome entry segment
The inability of the c-myc 5' UTR to inhibit translation in vivo compared to the previously demonstrated inhibition in vitro (Parkin et al., 1988 and our unpublished data) led us to test the hypothesis that it contains an IRES. We inserted the c-myc 5' UTR into a dicistronic reporter plasmid, pGL3R, in the spacer between the Renilla and ®re¯y luciferase cistrons (Figure 2a ). These plasmid constructs were then transfected into HeLa and HepG2 cells. The c-myc 5' UTR stimulated expression of the downstream cistron approximately 50-fold (Figure 2b ) when compared to the control plasmids which lack this sequence. The apparent increase in the translation of the downstream cistron on the dicistronic message containing the c-myc 5' UTR could result from various mechanisms. The 5' UTR may contain an element which stimulates readthrough past the Renilla luciferase cistron and thus causes reinitiation of translation at the downstream cistron. Alternatively, monocistronic ®re¯y luciferase mRNAs may be produced by transcriptional, RNA cleavage or splicing mechanisms. Finally, the c-myc 5' UTR may direct internal ribosome entry. To determine whether the 5' UTR is capable of stimulating readthrough from the upstream to the downstream cistron, a palindromic sequence which forms a stable RNA hairpin (755 Kcal/mol) was introduced into pGL3Rutr upstream of the Renilla luciferase coding sequence to inhibit ribosome scanning. The stem loop in the new vector, pGL3RutrH, reduced the renilla luciferase activity by 75% but the activity of the ®re¯y luciferase was unaected ( Figure  2c ). If enhanced ribosomal readthrough was responsible for the 5' UTR dependent stimulation of ®re¯y luciferase then this activity should be reduced by an equivalent amount.
To address the potential fragmentation of dicistronic mRNAs we performed RNase protection assays on RNA isolated from both HeLa cells transfected with pGL3Rutr and mock transfected cells. In transfected cells a 725 nt probe complementary to 624 nts of the 5' UTR containing dicistronic mRNA (see Figure 3a) protected a fragment of the expected size (Figure 3b , lane 3). In addition, protected fragments of 395 and 382 nts were detected in both transfected and mock transfected samples resulting from hybridisation of the probe to endogenous c-myc transcripts (Figure 3b,  lanes 2 and 3) . The presence of functional monocistronic transcripts would result in smaller protected fragments of at least 101 nts in length, and since no products of this size were detected the increased expression of ®re¯y luciferase must occur on intact discistronic mRNAs.
Thus we conclude that c-myc 5' UTR contains an IRES. The small, but reproducible, reduction in the expression of luciferase from the upstream cistron of between 15 ± 20% in the cells which contain the plasmid pGL3Rutr, is also consistent with this hypothesis (Figure 2b ). This probably re¯ects a competition between cap-dependent and IRES-dependent translation on the dicistronic mRNA and this phenomenon has also been observed for Bip, picornovirus and eIF4G IRESes (Macejak and Sarnow, 1991; Borman and Jackson, 1992; Gan and Rhodes, 1996) .
Mapping the c-myc IRES
To de®ne the boundaries of the c-myc IRES a series of plasmid constructs was generated containing decreasing lengths of the sequence coding for the 5' UTR. The ability of these truncated sequences to promote internal ribosome entry on a dicistronic mRNA was compared + mRNA was puri®ed from 10 mg of total RNA using oligo(dT) magnetic beads (Dynatec Inc). RNA samples were hybridised with 5610 5 c.p.m. of riboprobe at 458C for 16 h in hybridisation buer (40 mM PIPES pH 6.4, 400 mM NaCl, 1 mM EDTA, 80% deionised formamide). Single stranded RNA was digested using RNase ONE (Promega). The products were size fractionated on a 4% polyacrylamide/7 M urea gel and visualised by phosphorimage analysis (Molecular Dynamics). Product sizes were determined using At the 3' end, deletion of 56 nts had no eect on the activity of the downstream cistron. However, deletions further upstream removing 84 and 158 nts reduced the eciency of the internal ribosome entry by 40 and 60% respectively (Figure 4 ). Hence the 3' end of the optimally eective IRES lies between 312 and 340 nts from the 5' end. Furthermore, this analysis suggests a mechanistic distinction between viral IRESes and the cmyc IRES. In various viral IRESes 3' end deletions that lie within the IRES completely ablate internal ribosome entry (Pelletier and Sonenberg, 1988; Borman and Jackson, 1992; Borman et al., 1995; , whereas c-myc IRES 3' end deletions result in a gradual loss of activity. This may re¯ect a structural dierence between cellular and viral IRESes. We have performed phylogenetic and energy minimization analyses on the c-myc 5' UTR and obtained a model for the secondary structure ( Figure 5 ). Noteworthy features include the high degree of foldback in the structure when compared to those predicted for viral IRESes, and the absence of cryptic AUGs in all sequences examined.
The preceding data demonstrate that the c-myc 5' UTR contains a translational element capable of directing internal ribosome entry and we propose that c-myc protein synthesis may therefore be initiated by such a mechanism. This suggests that the c-myc protein can be translated under situations where initiation from the 5' cap structure and ribosome scanning is reduced. There are a number of situations where modulation in the levels of c-myc protein via internal ribosome entry may be required including the onset of proliferation, during mitosis where cap-dependent translation is reduced and following DNA damage (Sullivan and Willis, 1989) .
Deregulation of the c-myc proto-oncogene through enhanced internal ribosome entry could play a pivotal role in tumour development. We have described previously two cases where deregulation of c-myc by translational mechanisms occurs in cell lines derived from patients with Bloom's syndrome (West et al., 1995) and in multiple myeloma (Paulin et al., 1996) .
Further work is merited to investigate the mechanism of action of this IRES, the pathophysiological circumstances under which it is used and the eects that the mutation in this region has on the aberrant translational regulation of c-myc in multiple myeloma. Figure 1 ). These sequences were inserted into pGL3R at the PvuII and NcoI sites. Deletions from the 3' end were produced by digesting the c-myc 5' UTR with PvuII, EcoR0901I and AvaI, generating fragments of 340, 312 and 238 bp. Fragments were inserted by blunt-end ligation into the PvuII site of pGL3R. The resulting constructs were then transfected into HeLa cells and luciferase activity measured and calculated as before. The reduction in luciferase activity from the downstream cistron is expressed as percentage of the values obtained with pGL3Rutr Figure 5 Model for the secondary structure of the c-myc IRES. Energy minimization analysis was performed using M Zuker's mfold' package (Zuker, 1989) . Phylogenetic analysis was performed on aligned sequences derived from human, gibbon, marmoset, woodchuck, mouse, rat, cat, sheep and pig tissues. The model was drawn using the`CARD' program (Winnenpenninckx et al., 1995) 
